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range. It is therefore advantageous to use light to detect pre-invasive 
lung caner and preneoplastic lesions that are usually very thin and small.
When tissue is illuminated by light, the light can be absorbed, scattered, 
induce ﬂuorescence or vibration changes. Signiﬁcant differences in 
reﬂectance and autoﬂuorescence properties have been observed between 
normal, pre-malignant and malignant tissues. These differences in 
optical properties have been exploited to enhance the detection rate of 
high-grade bronchial dysplasia and carcinoma in-situ. Current commer-
cially available autoﬂuorescence bronchoscopy devices make use of a 
combination of autoﬂuorescence and reﬂectance. A blue or violet light is 
used to induce tissue autoﬂuorescence. The ﬂuorescence image is then 
combined with a blue, red and/or green reﬂectance image for display. 
In addition to multiple single center studies, there are 3 multi-center 
clinical trials and two randomized trials that showed improved detection 
rate with ﬂuorescence bronchoscopy or with ﬂuorescence-reﬂectance 
bronchoscopy compared to white-light bronchosocpy alone. Autoﬂuo-
rescence bronchoscopy has the advantage that a biopsy can be taken 
during the same examination for pathological conﬁrmation. For cancer 
beyond the range of the bronchoscope, gene expression analysis of 
bronchial brush cells holds promise to differentiate between malignant 
versus benign peripheral lung nodules. Autoﬂuorescence bronchoscopy 
has contributed to improved histopathological classiﬁcation and molecu-
lar proﬁling of preneoplastic lesions. It has become an integral part of a 
standard bronchoscopic examination for lung cancer diagnosis.
False-positive ﬂuorescence can occur due to inﬂammation or conditions 
that increase vascularity of the bronchial mucosa. Optical coherence 
tomography (OCT) can overcome this problem by allowing visualiza-
tion of the sup-epithelial layers. The principle of OCT is similar to ul-
trasound. Instead of using sound, infrared light is used. Back-scattered 
light from varying tissue depths can be used to delineate cellular and 
extra-cellular structures. Doppler OCT can add further information on 
vascular density and blood ﬂow. Recent studies showed that high-grade 
dysplasia, carcinoma in-situ and invasive cancer can be distinguished 
from normal, hyperplastic or metaplastic epithelium. Interruption of the 
basement membrane would indicate the presence of invasive cancer. 
Areas of inﬂammation also show distinctive changes. Since small pre-
neoplastic lesions can be removed by a biopsy procedure, OCT holds 
promise as a non-biopsy tool to study the natural history of preneoplas-
tic lesions and the effect of chemoprevention.
In the context of an early lung cancer detection program, approximately 
18% of cancers - majority of which being Stage 0 caners, are detected 
by ﬂuorescence bronchoscopy alone with a negative spiral CT. Lung 
cancer risk assessment models using biometric data such as family 
history, presence or absence of chronic obstructive pulmonary disease, 
family history of lung cancer and body mass index in addition to age, 
smoking history and occupational exposure are being validated. These 
models have the potential to predict the risk of lung cancer develop-
ment better than the Gail model for breast cancer. Prospective clinical 
trials need to be performed to validate the use of these lung cancer risk 
models to select individuals at highest risk of developing lung cancer 
for intensive screening utilizing both ﬂuorescence-reﬂectance bron-
choscopy and spiral CT to detect early cancer in both the central and 
peripheral airways that are amendable to curative therapies.
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Endobronchial ultrasound (EBUS) guided biopsy in respiratory disease 
is a promising new modality. The radial probe EBUS (20 MHz) has 
been used for the biopsy of peripheral lung lesions using the guide 
sheath. In addition, the radial probe EBUS guided TBNA has increased 
the yield of TBNA of mediastinal lymph nodes. However it is still not 
a real-time procedure with target visualization. To overcome these 
problems, a new convex probe endobronchial ultrasound (CP-EBUS, 
XBF- UC260F-OL8) with ability to perform real-time EBUS guided 
TBNA (EBUS-TBNA) was developed in collaboration with Olympus 
Optical Co. Tokyo, Japan 1, 2. This CP-EBUS is a ﬂexible bronchoscope 
with a linear curved array transducer on the tip with a frequency of 7.5 
MHz that scans parallel to the insertion direction of the bronchoscope. 
Images can be obtained by directly contacting the probe or by attaching 
a balloon on the tip and inﬂating with saline. The outer diameter of the 
insertion tube of the ﬂexible bronchoscope is 6.7 mm and that of the 
tip is 6.9 mm. A dedicated 22-gauge needle was developed to perform 
transbronchial aspiration. The needle can be visualized through the 
optics and on the ultrasound image. 
EBUS-TBNA was initially developed for lymph node staging of lung 
cancer. However from our experience, there are many other uses in 
clinical practice. The applications of EBUS-TBNA are (a) lymph node 
staging in lung cancer patients; (b) diagnosis of intrapulmonary tumors; 
(c) diagnosis of unknown hilar and/or mediastinal lymphadenopathy; 
and (d) diagnosis of mediastinal tumors. From our 5 year experience, 
we have not experienced any major complications. 
For lymph node assessment in lung cancer patients, EBUS-TBNA can 
be used for preoperative evaluation as well as post-chemotherapy and 
post-operative evaluation. To evaluate the usefulness of CP-EBUS 
in pre-operative lymph node staging of lung cancer, we performed 
EBUS-TBNA in 108 patients with lung cancer or suspected lung cancer 
having mediastinal lymph nodes suspected of malignancy. In 105 
patients, EBUS-TBNA was successfully performed to obtain samples 
from 163 lymph nodes. With respect to the correct prediction of lymph 
node stage, EBUS-TBNA had a sensitivity of 94.6%, speciﬁcity of 
100%, positive predictive value of 100%, negative predictive value of 
89.5%, and diagnostic accuracy rate of 96.3%. In the 20 suspected lung 
cancer cases, mediastinal lymph node was used for tissue diagnosis of 
malignancy as well as staging. As a result of EBUS-TBNA, 29 medias-
tinoscopies, 8 thoracotomies, 4 thoracoscopies, and 9 CT-guided PCNB 
were avoided 3. In addition, a cost effectiveness study comparing 
EBUS-TBNA to other conventional tools used for mediastinal staging 
Copyright © 2007 by the International Association for the Study of Lung Cancer S239
Journal of Thoracic Oncology • Volume 2, Number 8, Supplement 4, August 2007  12th World Conference on Lung Cancer
showed favorable results for EBUS-TBNA. A comparison of EBUS-
TBNA with CT and PET has shown favorable results for EBUS-TBNA 
in the lymph node staging of lung cancer 4.
During the assessment of lung tumors, we may come across cases 
where tumors are located adjacent to the bronchus, but inconclusive 
results from conventional bronchoscopic biopsy procedures. CP-EBUS 
can be used for real-time biopsies of tumors adjacent to the airways. 
In our experience in 27 patients with intrapulmonary lung tumors, the 
diagnostic yield was 89%. Conventional bronchoscopy prior to EBUS-
TBNA was non-diagnostic in 22 out of the 27 cases. Cytological and/or 
histological samples were diagnostic in 24 patients. 
Sarcoidosis should be substantiated by pathological means in order 
well to exclude other diseases. The role of EBUS-TBNA in diagnosis 
of sarcoidosis has also been proven to be effective. In 65 patients with 
suspected sarcoidosis with enlarged hilar or mediastinal lymph nodes 
EBUS-TBNA was performed on a total of 77 lymph node station. The 
ﬁnal diagnosis of sarcoidosis was given in 61 patients (93.8%). The 
remaining 4 patients were diagnosed as Wegener’s granulomatosis 
(n=1) or indeﬁnite (n=3). In patients with ﬁnal diagnosis of sarcoidosis, 
EBUS-TBNA demonstrated noncaseating epithelioid cell granulomas 
in 56 patients (91.8%) 5. Ongoing studies are looking at the comparison 
of EBUS-TBNA with other conventional modalities.
EBUS-TBNA is also useful for the assessment of mediastinal tumors. 
Mediastinal cysts are easy to evaluate with EBUS-TBNA. Other medi-
astinal tumors diagnosed by EBUS-TBNA in our department include 
lung cancer, lymphoma, thymic cancer, and mediastinal goiter. Com-
pared to diagnosis of lymph node metastasis in lung cancer patients, cy-
tological diagnosis of mediastinal tumors is often times more difﬁcult. 
Lymphoma seems to be the most challenging among the mediastinal 
tumors. To solve this problem, there is a need for a larger needle which 
will allow a ﬁrm diagnosis by histological specimens.
Although the diagnostic yield of EBUS-TBNA reported up-to-date is 
quite high, there are disadvantages as well. EBUS-TBNA cannot access 
the subaortic and paraesophageal lymph nodes. For the assessment of 
paraesophageal lymph nodes, EUS-FNA is the examination of choice. 
Another disadvantage of EBUS-TBNA is the difﬁculties of the proce-
dure. The direction of view of the scope is 30 degrees forward oblique 
making the manipulation a little difﬁcult. Ten to 20 procedures in the 
hands of an experienced bronchoscopist is probably needed to be able 
to perform EBUS-TBNA smoothly. 
EBUS-TBNA is a novel approach that is safe and has a good diagnostic 
yield. This new ultrasound puncture bronchoscope has an excellent po-
tential in assisting safe and accurate diagnostic interventional bronchos-
copy in respiratory diseases. Further prospective studies describing the 
diagnostic yield of EBUS-TBNA compared to other conventional tools 
will be needed to support the value of this new modality.
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Introduction
During the last decade, several new technologies have been introduced 
to the ﬁeld of bronchoscopy. Among them, the electromagnetic naviga-
tion systems have been approved by regulatory organizations and are 
now available. As experience with these technologies has increased, 
the body of published literature has grown. In this review we assess the 
most important and interesting articles in the ﬁeld.
Electromagnetic navigation
More than 150,000 solitary pulmonary nodules are reported each year 
in the United States (1). As the popularity of CT scan use for screen-
ing grows, these numbers are likely to increase substantially (2). More 
than 6.5 million CT scans of the chest were performed in the United 
states alone in 2001, highlighting the potential for this clinical situation. 
Detecting a nodule on either a chest radiograph or a CTscan frequently 
leads to a cascade of further investigations to establish a deﬁnite diagno-
sis. Performing thoracic surgery to obtain a tissue diagnosis is a frequent 
clinical scenario and, unfortunately, surgery is frequently performed 
for what turns out to be benign abnormalities. Conventional ﬂexible 
bronchoscopy, one of the least invasive chest procedures, is of limited 
value for obtaining a tissue diagnosis when such lesions are located in 
the peripheral segments of the lung. Historically, the diagnostic yield is 
speciﬁcally compromised if the lesion is less than 2 cm (3, 4). Flex-
ible bronchoscopy is limited mainly because of difﬁculties in reaching 
peripheral lesions with the ﬂexible endobronchial accessories, and local-
izing the lesion precisely under ﬂuoroscopy is frequently difﬁcult. Addi-
tionally, instruments currently used with a ﬂexible bronchoscope are not 
actively steerable but must be advanced in a ‘hit-or-miss’ fashion.
If issues of diagnostic yield could be resolved, ﬂexible bronchoscopy 
would represent a very interesting part in the workup and management 
of lung lesions. What are needed, therefore, are new methods for navi-
gation and localization, independent of visualization by ﬂuoroscopy 
and the technical skills of the bronchoscopist. A promising new tech-
nology is electromagnetic navigation based on virtual bronchoscopy 
and real-time three-dimensional CT scans.
Instrument
The electromagnetic navigation system is a localization device that as-
sists in placing endobronchial accessories (e.g., forceps, brush, needle) 
in the desired areas of the lung. The system uses low-frequency elec-
tromagnetic waves, which are emitted from an electromagnetic board 
placed under the bronchoscopy table mattress. A 1 mm diameter,
8 mm-long sensor probe mounted on the tip of a ﬂexible metal cable 
constitutes the main assembly of the device (locatable guide). Once the 
probe is placed within the electromagnetic ﬁeld, its position in the X, Y, 
and Z planes, as well as its orientation (roll, pitch, and yaw movements) 
are captured by the electromagnetic navigation system. This informa-
tion is then displayed on a monitor in real time. The locatable guide 
also has an added feature that allows its distal section to be steered 
